outcomes research

Research in Review

Chemotherapy After Surgery Improves Survival in Biliary Tract Cancer

05/18/2017

JCP Editors

Administering capecitabine after surgery extends survival by a median of 17 months compared with surgery alone for patients with biliary tract cancer, according to research that will be presented at the 2017 ASCO...

...

05/18/2017

Journal of Clinical Pathways

Research in Review

New Therapy May Effectively Treat Rare B-Cell Malignancy

05/18/2017

JCP Editors

A new treatment for a rare B-cell malignancy provided an objective response rate of 41% in a clinical trial, published in Blood (published online May 10, 2017; doi:10.1182/blood-2016-12-758383). ----- Related...

A new...

05/18/2017

Journal of Clinical Pathways

Research in Review

TKI Discontinuation Improves Remission Rates for Patients With CML

03/03/2017

JCP Editors

Patients with chronic myeloid leukemia (CML) who discontinued treatment with second-generation tyrosine kinase inhibitors (TKIs) benefited from significant treatment-free remission rates, according to research...

...

03/03/2017

Journal of Clinical Pathways

Research in Review

Imatinib Treatment for GISTs Leads to Long-Term Survival in Certain Patients

02/22/2017

JCP Editors

Imatinib mesylate front-line treatment of advanced or metastatic gastrointestinal stromal tumors (GISTs) leads to significant long-term survival in patients with a specific genetic mutation, according to study...

...

02/22/2017

Journal of Clinical Pathways

Research in Review

Frailty Screening May Improve Outcomes for Older Surgical Patients

02/13/2017

JCP Editors

The utilization of a novel preoperative frailty screening system reduced mortality up to 365 days postsurgery and may serve as an easily implementable tool for assessing older surgical patients, according to research...

The...

02/13/2017

Journal of Clinical Pathways

Research in Review

Cardiotoxicity Among Childhood Cancer Survivors Decreasing Over Time

01/24/2017

JCP Editors

Initiatives to reduce cardiotoxicity among childhood patients with cancer treated more recently have had a measurable impact over time, according to research published in Circulation. ----- Related Content Risk of...

...

01/24/2017

Journal of Clinical Pathways

Interview

Making Decisions About New Cancer Treatments With Limited Evidence

11/15/2016

Jim C Hu, MD, MPH

An interview with Jim C Hu, MD, MPH, urologic oncologist and director of the LeFrak Center for Robotic Surgery at NewYork-Presbyterian and Weill Cornell Medicine, New York, NY.  Prostate cancer...

An...

11/15/2016

Journal of Clinical Pathways

Research in Review

N-Acetyle Cysteine Improves Immunotherapy for Melanoma

10/18/2016

JCP Editors

Culturing T cells in N-acetyle cysteine (NAC) before they are infused as immunotherapy may improve effectiveness and outcomes in patients with melanoma, according to findings reported in Cancer Research....

...

10/18/2016

Journal of Clinical Pathways

Research in Review

CML Mutations Associated With Treatment Failure

10/18/2016

JCP Editors

Somatic mutations may predict treatment failure with tyrosine kinase inhibitors (TKIs) in patients with chronic myeloid leukemia (CML), according to a study published in Blood, the journal of the American Society of...

...

10/18/2016

Journal of Clinical Pathways

Research in Review

PRRT Use Supported by More than 10 Years of Evidence

10/18/2016

JCP Editors

A review of more than 10 years of published clinical data supports the use of peptide receptor radionuclide therapy (PRRT)-containing regimens as a way of improving outcomes, minimizing toxicity, and reducing the...

A...

10/18/2016

Journal of Clinical Pathways